Cancer research
Researchers at the University of Kentucky have made new discoveries in cancer gene therapy, specifically focusing on the role of OCT4 in mediating lineage plasticity in prostate cancer. The study, published in the journal Biomedicines, highlights the importance of understanding the molecular mechanisms underlying OCT4-driven plasticity to develop novel therapeutic
Cancer research
City of Hope's Research Spotlight highlights cutting-edge discoveries in cancer, diabetes, and other life-threatening diseases, offering new hope to patients worldwide. A recent study on a new drug combination has shown potential in slowing the spread of advanced prostate cancer, while a novel AI tool is revolutionizing cancer
Cancer
Women of childbearing age are disproportionately affected by female cancers such as breast, cervical, ovarian, and uterine cancer. A recent study published in Translational Oncology concludes that human papillomavirus (HPV) vaccines are essential in preventing these cancers. The study estimates that the global incidence of breast, uterine, cervical, and ovarian
Cancer
The FDA has recently updated the indication for Skysona, a gene therapy developed by bluebird bio, to restrict its use in patients who do not have an available human leukocyte antigen (HLA)-matched donor for stem cell transplant. This decision comes after the agency expressed concerns about an increased risk
Cancer research
Researchers at the University of Missouri have made significant progress in developing a new therapeutic approach for brain cancer, utilizing exosomes as a drug delivery system. This innovative method has shown promise in overcoming the blood-brain barrier, ensuring efficient cellular uptake, and ultimately, leading to cytotoxicity in glioblastoma cells. The
Cancer
Researchers from Soochow University have made significant progress in cancer gene therapy, developing a novel mRNA delivery system that achieves nearly 100% organ-specific transfection in various tissues, including pancreas, lymph nodes, brain, and spleen. The system, called ACCOST (Administration Route-commended Concise Organ-selective mRNA Transfection), uses a cyclic disulfide-primed short polyethyleneimine
Cancer research
Researchers at Chongqing Medical University in China have made significant advancements in the field of cancer immunotherapy. According to a recent study published in the Journal for ImmunoTherapy of Cancer, investigators have discovered that shared neoantigens, including KRAS, TP53, and PIK3CA mutations, have substantial immunogenicity and offer promising therapeutic potential
Cancer research
A new research study published in Aggregate journal presents a promising approach to overcome current limitations in immune checkpoint blockade (ICB) therapies for treating oral squamous cell carcinoma (OSCC). The researchers from Sichuan Cancer Hospital & Institute developed an immunostimulatory nanovaccine using tetrahedral framework nucleic acids (tFNAs) as a carrier
Cancer research
Researchers from the University of Queensland have made significant breakthroughs in generating induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells for cancer immunotherapy. According to a recent review published in Clinical & Translational Immunology, these cells hold promise as a scalable, consistent, and inexhaustible source of genetically modifiable
Cancer
Scientists at the University of Ramon Llull have made a significant breakthrough in cancer gene therapy by developing a simplified nanovehicle formulation that enables enhanced gene delivery across a cell-based model of the blood-brain barrier. The novel approach uses a single polymer, pBAE-CRHR-Zw, which is designed to decrease unspecific transfection
Cancer
Researchers from the South China University of Technology have proposed a novel biomimetic nanoplatform for precise and selective cancer therapy. This innovative approach involves the use of enzyme-mediated activation of natural cytolytic peptides (NCPs) within tumor microenvironments, minimizing non-selective cytotoxicity and hemolysis. The biomimetic ferritin nanoparticles (MMFn) are designed to
Cancer
Researchers at Islamic Azad University in Tehran, Iran, have conducted a study to assess the anticancer effects of Pt-Rb and Pt-AZT on HepG2 cells. The study aimed to compare the efficacy of these two compounds in inducing apoptosis and modulating gene expression. The results showed that Pt-Rb exhibited stronger anticancer
